@article{10709,
  keywords = {Aged, Female, Humans, Male, Middle Aged, Algorithms, *Diabetes Mellitus, Type 2/drug therapy, *Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Hypoglycemic Agents/therapeutic use, Retrospective Studies, Sodium-Glucose Transporter 2/therapeutic use, *Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Clinical Trials as Topic},
  author = {J. Dennis and K. Young and A. McGovern and B. Mateen and S. Vollmer and M. Simpson and W. Henley and R. Holman and N. Sattar and E. Pearson and A. Hattersley and A. Jones and B. Shields},
  title = {Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study},
  year = {2022},
  journal = {Lancet Digit Health},
  volume = {4},
  edition = {2022/11/26},
  number = {12},
  pages = {e873-e883},
  isbn = {2589-7500},
  doi = {10.1016/s2589-7500(22)00174-1},
  note = {2589-7500
Dennis, John M
Young, Katherine G
McGovern, Andrew P
Mateen, Bilal A
Vollmer, Sebastian J
Simpson, Michael D
Henley, William E
Holman, Rury R
Sattar, Naveed
Pearson, Ewan R
Hattersley, Andrew T
Jones, Angus G
Shields, Beverley M
MASTERMIND consortium
Journal Article
England
Lancet Digit Health. 2022 Dec;4(12):e873-e883. doi: 10.1016/S2589-7500(22)00174-1.},
  language = {eng},
}